Galactorrhoea, hyperprolactinaemia, and protease inhibitors.
Montero
A
A
Bottasso
O A
OA
Luraghi
M R
MR
Giovannoni
A G
AG
Sen
L
L
D017088:AIDS-Related Opportunistic Infections / Q000097:blood / Q000188:drug therapy; D000328:Adult; D005260:Female; D005687:Galactorrhea / Q000097:blood / Q000139:chemically induced*; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D015497:HIV-1; D006801:Humans; D006966:Hyperprolactinemia / Q000097:blood / Q000139:chemically induced*; D008297:Male; D011388:Prolactin / Q000097:blood
D017320:HIV Protease Inhibitors; D011388:Prolactin